{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T20:58:24Z","timestamp":1780865904854,"version":"3.54.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104112"],"award-info":[{"award-number":["82104112"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.colsurfb.2026.115434","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T07:42:06Z","timestamp":1768030926000},"page":"115434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Lysosome-targeted ROS-responsive graphene oxide-based drug delivery system to overcome tumor DOX resistance"],"prefix":"10.1016","volume":"261","author":[{"given":"Fengzhu","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jintao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengbao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhua","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.colsurfb.2026.115434_bib1","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1073\/pnas.1418494112","article-title":"Anticancer drug nanomicelles formed by self-assembling amphiphilic dendrimer to combat cancer drug resistance","volume":"112","author":"Wei","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.colsurfb.2026.115434_bib2","article-title":"ABC transporters affects tumor immune microenvironment to regulate cancer immunotherapy and multidrug resistance, Drug resist","volume":"66","author":"Fan","year":"2022","journal-title":"Update"},{"key":"10.1016\/j.colsurfb.2026.115434_bib3","doi-asserted-by":"crossref","DOI":"10.1186\/s13578-020-00489-x","article-title":"The role of lysosomes in cancer development and progression","volume":"10","author":"Tang","year":"2020","journal-title":"Cell Biosci."},{"key":"10.1016\/j.colsurfb.2026.115434_bib4","doi-asserted-by":"crossref","first-page":"e293","DOI":"10.1038\/cddis.2012.30","article-title":"Imidazoacridinone-dependent lysosomal photodestruction: a pharmacological Trojan horse approach to eradicate multidrug-resistant cancers","volume":"3","author":"Adar","year":"2012","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.colsurfb.2026.115434_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108488","article-title":"Strategies to overcome cancer multidrug resistance (MDR) through targeting P-glycoprotein (ABCB1): An updated review","volume":"249","author":"Dong","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.colsurfb.2026.115434_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114643","article-title":"Overcoming Cancer Multi-drug Resistance (MDR): Reasons, mechanisms, nanotherapeutic solutions, and challenges","volume":"162","author":"Duan","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.colsurfb.2026.115434_bib7","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.18632\/oncotarget.2732","article-title":"Lysosomal sequestration of hydrophobic weak base chemotherapeutics triggers lysosomal biogenesis and lysosome-dependent cancer multidrug resistance","volume":"6","author":"Zhitomirsky","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.colsurfb.2026.115434_bib8","doi-asserted-by":"crossref","first-page":"9588","DOI":"10.1074\/jbc.M114.631283","article-title":"Di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT) overcomes multidrug resistance by a novel mechanism involving the hijacking of lysosomal P-glycoprotein (Pgp)*","volume":"290","author":"Jansson","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.colsurfb.2026.115434_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2020.100704","article-title":"Nanomedicine to target multidrug resistant tumors","volume":"52","author":"Lepeltier","year":"2020","journal-title":"Drug Resist. Update"},{"key":"10.1016\/j.colsurfb.2026.115434_bib10","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1080\/10717544.2022.2079771","article-title":"Recent advances in anti-multidrug resistance for nano-drug delivery system","volume":"29","author":"Wang","year":"2022","journal-title":"Drug Deliv."},{"key":"10.1016\/j.colsurfb.2026.115434_bib11","doi-asserted-by":"crossref","first-page":"7153","DOI":"10.1039\/C5TB00956A","article-title":"An overview of nanotoxicity and nanomedicine research: principles, progress and implications for cancer therapy","volume":"3","author":"Wang","year":"2015","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.colsurfb.2026.115434_bib12","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jmst.2024.07.002","article-title":"Near-infrared-II triggered inorganic photodynamic nanomedicines for deep-tissue therapy","volume":"213","author":"Tang","year":"2025","journal-title":"J. Mater. Sci. Technol."},{"key":"10.1016\/j.colsurfb.2026.115434_bib13","doi-asserted-by":"crossref","first-page":"10168","DOI":"10.1021\/nn502986e","article-title":"Graphene oxide enhances cellular delivery of hydrophilic small molecules by co-incubation","volume":"8","author":"Hung","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.colsurfb.2026.115434_bib14","doi-asserted-by":"crossref","first-page":"9182","DOI":"10.1039\/C5TB02057C","article-title":"Receptor-targeting fluorescence imaging and theranostics using a graphene oxide based supramolecular glycocomposite","volume":"3","author":"Ji","year":"2015","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.colsurfb.2026.115434_bib15","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jconrel.2022.08.011","article-title":"Multifunctional graphene oxide nanoparticles for drug delivery in cancer","volume":"350","author":"Itoo","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2026.115434_bib16","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.actbio.2020.04.009","article-title":"Delivery of MutT homolog 1 inhibitor by functionalized graphene oxide nanoparticles for enhanced chemo-photodynamic therapy triggers cell death in osteosarcoma","volume":"109","author":"Huang","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.colsurfb.2026.115434_bib17","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jconrel.2021.02.030","article-title":"Recent advances of redox-responsive nanoplatforms for tumor theranostics","volume":"332","author":"Chen","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2026.115434_bib18","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.vph.2009.01.001","article-title":"ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat","volume":"50","author":"Sacco","year":"2009","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.colsurfb.2026.115434_bib19","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4274\/Tjh.2012.0013","article-title":"The role of nitric oxide in Doxorubicin-induced cardiotoxicity: experimental study","volume":"31","author":"Bahad\u0131r","year":"2014","journal-title":"Turk. J. Hematol."},{"key":"10.1016\/j.colsurfb.2026.115434_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121856","article-title":"Activating cGAS-STING pathway with ROS-responsive nanoparticles delivering a hybrid prodrug for enhanced chemo-immunotherapy","volume":"290","author":"Cao","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.colsurfb.2026.115434_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.916952","article-title":"Recent Progress in Bio-Responsive Drug Delivery Systems for Tumor Therapy","volume":"10","author":"Cong","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.colsurfb.2026.115434_bib22","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1039\/D1CS00762A","article-title":"Proteolysis-targeting chimera (PROTAC) delivery system: advancing protein degraders towards clinical translation","volume":"51","author":"Chen","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.colsurfb.2026.115434_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122835","article-title":"Novel platinum therapeutics induce rapid cancer cell death through triggering intracellular ROS storm","volume":"314","author":"Liu","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.colsurfb.2026.115434_bib24","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.freeradbiomed.2016.04.201","article-title":"Turning the Gun on Cancer: Utilizing Lysosomal P-Glycoprotein as a New Strategy to Overcome Multi-Drug Resistance","author":"Seebacher","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.colsurfb.2026.115434_bib25","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.1074\/jbc.M115.682450","article-title":"Glucose Modulation Induces Lysosome Formation and Increases Lysosomotropic Drug Sequestration via the P-Glycoprotein Drug Transporter","volume":"291","author":"Seebacher","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.colsurfb.2026.115434_bib26","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1182\/blood-2004-03-0868","article-title":"Novel di-2-pyridyl-derived iron chelators with marked and selective antitumor activity: in vitro and in vivo assessment","volume":"104","author":"Yuan","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.colsurfb.2026.115434_bib27","doi-asserted-by":"crossref","first-page":"e2510","DOI":"10.1038\/cddis.2016.381","article-title":"A mechanism for overcoming P-glycoprotein-mediated drug resistance: novel combination therapy that releases stored doxorubicin from lysosomes via lysosomal permeabilization using Dp44mT or DpC","volume":"7","author":"Seebacher","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.colsurfb.2026.115434_bib28","doi-asserted-by":"crossref","first-page":"6510","DOI":"10.1021\/jm0606342","article-title":"Dipyridyl Thiosemicarbazone Chelators with Potent and Selective Antitumor Activity Form Iron Complexes with Redox Activity","volume":"49","author":"Richardson","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.colsurfb.2026.115434_bib29","doi-asserted-by":"crossref","first-page":"33568","DOI":"10.1074\/jbc.M114.599480","article-title":"The anticancer agent di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT) overcomes prosurvival autophagy by two mechanisms: persistent induction of autophagosome synthesis and impairment of lysosomal integrity","volume":"289","author":"Gutierrez","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.colsurfb.2026.115434_bib30","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2018.08.037","article-title":"A tumor targeted near-infrared light-controlled nanocomposite to combat with multidrug resistance of cancer","volume":"288","author":"Wang","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2026.115434_bib31","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3109\/02652048.2014.940010","article-title":"Folate-modified pluronic-polyethylenimine and cholic acid polyion complex micelles as targeted drug delivery system for paclitaxel","volume":"31","author":"Li","year":"2014","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.colsurfb.2026.115434_bib32","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.2042-7158.2012.01567.x","article-title":"Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems","volume":"65","author":"Tacar","year":"2013","journal-title":"J. Pharm. Pharm."},{"key":"10.1016\/j.colsurfb.2026.115434_bib33","doi-asserted-by":"crossref","first-page":"13352","DOI":"10.1002\/chem.202000389","article-title":"Meticulous Doxorubicin Release from pH-Responsive Nanoparticles Entrapped within an Injectable Thermoresponsive Depot","volume":"26","author":"Yu","year":"2020","journal-title":"Chemistry"},{"key":"10.1016\/j.colsurfb.2026.115434_bib34","first-page":"347","article-title":"Doxorubicin-conjugated pH-responsive gold nanorods for combined photothermal therapy and chemotherapy of cancer","volume":"3","author":"Chen","year":"2018","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.colsurfb.2026.115434_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115036","article-title":"Molecular mechanisms of ROS-modulated cancer chemoresistance and therapeutic strategies","volume":"165","author":"Zhou","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.colsurfb.2026.115434_bib36","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7053451","article-title":"Long-term alteration of reactive oxygen species led to multidrug resistance in MCF-7 cells","volume":"2016","author":"Cen","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.colsurfb.2026.115434_bib37","article-title":"Metabolomics integrated genomics approach: Understanding multidrug resistance phenotype in MCF-7 breast cancer cells exposed to doxorubicin and ABCA1\/EGFR\/PI3k\/PTEN crosstalk","volume":"14","author":"Kadry","year":"2025","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.colsurfb.2026.115434_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114281","article-title":"pH-redox responsive cascade-targeted liposomes to intelligently deliver doxorubicin prodrugs and lonidamine for glioma","volume":"235","author":"Zhao","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.colsurfb.2026.115434_bib39","doi-asserted-by":"crossref","DOI":"10.34133\/research.0148","article-title":"Advanced Strategies for Overcoming Endosomal\/Lysosomal Barrier in Nanodrug Delivery","volume":"6","author":"Qiu","year":"2023","journal-title":"Research"},{"key":"10.1016\/j.colsurfb.2026.115434_bib40","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1039\/C2TB00004K","article-title":"Self-assembling doxorubicin prodrug forming nanoparticles for cancer chemotherapy: synthesis and anticancer study in vitro and in vivo","volume":"1","author":"Gou","year":"2012","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.colsurfb.2026.115434_bib41","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.actbio.2024.08.021","article-title":"Spatially confined photoacoustic effects of responsive nanoassembly boosts lysosomal membrane permeabilization and immunotherapy of triple-negative breast cancer","volume":"187","author":"Li","year":"2024","journal-title":"Acta Biomater."},{"key":"10.1016\/j.colsurfb.2026.115434_bib42","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/tra.12839","article-title":"Current methods to analyze lysosome morphology, positioning, motility and function","volume":"23","author":"Barral","year":"2022","journal-title":"Traffic"},{"key":"10.1016\/j.colsurfb.2026.115434_bib43","doi-asserted-by":"crossref","first-page":"e1510","DOI":"10.1038\/cddis.2014.468","article-title":"Bortezomib enhances cancer cell death by blocking the autophagic flux through stimulating ERK phosphorylation","volume":"5","author":"Kao","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.colsurfb.2026.115434_bib44","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.biopha.2011.12.002","article-title":"The different regulatory effects of p53 status on multidrug resistance are determined by autophagy in ovarian cancer cells","volume":"66","author":"Kong","year":"2012","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.colsurfb.2026.115434_bib45","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.1007\/s00210-023-02916-5","article-title":"Arenobufagin regulates the p62-Keap1-Nrf2 pathway to induce autophagy-dependent ferroptosis in HepG2 cells","volume":"397","author":"Yang","year":"2024","journal-title":"N. S Arch. Pharmacol."},{"key":"10.1016\/j.colsurfb.2026.115434_bib46","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.7150\/thno.70852","article-title":"Drug-induced self-assembled nanovesicles for doxorubicin resistance reversal via autophagy inhibition and delivery synchronism","volume":"12","author":"Wang","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.colsurfb.2026.115434_bib47","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.3390\/ijms22041873","article-title":"Nanocarrier-Based Drug Delivery for Melanoma Therapeutics","volume":"22","author":"Song","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.colsurfb.2026.115434_bib48","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.2147\/IJN.S454004","article-title":"Advancements in Stimulus-Responsive Co-Delivery Nanocarriers for Enhanced Cancer Immunotherapy","volume":"19","author":"Zhang","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.colsurfb.2026.115434_bib49","article-title":"Autophagy and multidrug resistance in cancer","volume":"52","author":"Li","year":"2017","journal-title":"Chin. J. Cancer"},{"key":"10.1016\/j.colsurfb.2026.115434_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2021.102494","article-title":"Nanotherapeutics approaches to overcome P-glycoprotein-mediated multi-drug resistance in cancer","volume":"40","author":"Halder","year":"2022","journal-title":"Nanomed"},{"key":"10.1016\/j.colsurfb.2026.115434_bib51","doi-asserted-by":"crossref","first-page":"31761","DOI":"10.1074\/jbc.M113.514091","article-title":"P-glycoprotein mediates drug resistance via a novel mechanism involving lysosomal sequestration","volume":"288","author":"Yamagishi","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.colsurfb.2026.115434_bib52","article-title":"Modification of bacterial cells for in vivo remotely guided systems","volume":"10","author":"Rybkin","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.colsurfb.2026.115434_bib53","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.2217\/nnm-2016-0252","article-title":"Pluronic-attached polyamidoamine dendrimer conjugates overcome drug resistance in breast cancer","volume":"11","author":"Wang","year":"2016","journal-title":"Nanomed"}],"updated-by":[{"DOI":"10.1016\/j.colsurfb.2026.115820","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000}},{"DOI":"10.1016\/j.colsurfb.2026.115820","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000}}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776526000226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776526000226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T19:59:36Z","timestamp":1780862376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776526000226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":53,"alternative-id":["S0927776526000226"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2026.115434","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lysosome-targeted ROS-responsive graphene oxide-based drug delivery system to overcome tumor DOX resistance","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2026.115434","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115434"}}